The growth of the global Hollow Fiber Filtration
Market is driven by factors such as the rising preference for continuous
manufacturing, increasing use of single use technologies, and the rising
biopharmaceutical industry. In addition, emerging economies, and increased
investment cell-based research are expected to provide significant growth
opportunities for players in the market.
The global Hollow fiber filtration market is projected to reach USD 597 million by 2026 from USD 303 million in 2021, at a CAGR of 14.5% during the forecast period.
Market Segmentation:
Based on material, the market is segmented into
polymeric and ceramic. The polymeric segment is further sub segmented into
PS/PES, Polyvinylidene fluoride (PVDF), and Other polymeric materials. In 2020,
PS/PES membrane filters accounted for the largest market share as they are
designed to eliminate particulates during standard filtration. They have low
protein and drug binding characteristics and are stable at alkaline pH. PS/PES
membranes are recommended for aqueous applications and for biological samples.
These membranes offer high product recoveries due to characteristics such as
low affinity and adsorption. In biopharmaceutical industries, PS/PES membranes
are mostly used for ultrafiltration in downstream processing, product
concentration, and the filtration of biological and pharmaceutical solutions.
Based on application type, the market is segmented
into continuous cell perfusion, harvest and clarification, and concentration
and diafiltration. In 2020, continuous cell perfusion accounted for the largest
market share due to the advantages of hollow fibers in continuous cell perfusion,
such as enabling efficient cell separation (with low shear) and allowing robust
large-scale manufacturing.
Regional Analysis:
The Asia
Pacific market is projected to witness the highest
growth rate during the forecast period, primarily due to innovation, a giant
talent pool of scientists, low labor, and manufacturing costs. The region has
also witnessed mass production because of technology and a rise in continuous
manufacturing instead of batch production in the previous era.
Asia Pacific region is also a lucrative market for foreign investors, with key market players having their presence in the region. Over the last decade, CMOs in the Asia Pacific region have impacted the global pharmaceutical manufacturing market. Several small and medium-scale CMOs set up in APAC have obtained US FDA approval for their operations and completed GMP certifications, thus driving the regions market.
Top Key Players:
Prominent players in the Hollow Fiber
Filtration Market are Repligen Corporation (US), Danaher (US), Asahi
Kasei Corporation (Japan),
Parker-Hannifin Corp (US), Sartorius Stedim Biotech S.A (France),
TOYOBO CO., LTD (Japan),
and Cantel Medical (US). The key players in this market are focusing on
strategic expansions, and acquisition to expand their presence in the market.